Cross-walk of the Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH
出版年份 2023 全文链接
标题
Cross-walk of the Chronic Liver Disease Questionnaire for Nonalcoholic Steatohepatitis (CLDQ-NASH) and the EuroQol EQ-5D-5L in patients with NASH
作者
关键词
-
出版物
Health and Quality of Life Outcomes
Volume 21, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-10-14
DOI
10.1186/s12955-023-02195-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Trends in obesity prevalence and cardiometabolic risk factor control in US adults with diabetes, 1999–2020
- (2023) Gang Hu et al. Obesity
- The Association Between Obesity and the 5-Year Prevalence of Morbidity and Mortality Among Adults with Type 2 Diabetes
- (2023) Kristina S. Boye et al. Diabetes Therapy
- Current therapies and new developments in NASH
- (2022) Jean-François Dufour et al. GUT
- The Economic Burden of Non-Alcoholic Steatohepatitis: A Systematic Review
- (2022) Michal Witkowski et al. PHARMACOECONOMICS
- The epidemiology of non-alcoholic steatohepatitis (NASH) in the United States between 2010-2020: a population-based study
- (2022) Osama Hamid et al. Annals of Hepatology
- Type 2 diabetes
- (2022) Ehtasham Ahmad et al. LANCET
- Cross-walk of the Assessment of Spondyloarthritis International Society Health Index and Ankylosing Spondylitis Quality of Life Scores in Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis Patients
- (2021) James Pike et al. Rheumatology and Therapy
- Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis
- (2021) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
- (2021) Hong Sun et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples
- (2020) Ruixuan Jiang et al. QUALITY OF LIFE RESEARCH
- Validation of Chronic Liver Disease Questionnaire for Non-Alcoholic Steatohepatitis in Patients with Biopsy-Proven Non-alcoholic Steatohepatitis
- (2019) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- Reduced Patient-Reported Outcome Scores Associate with Level of Fibrosis in Patients with Nonalcoholic Steatohepatitis
- (2019) Zobair M. Younossi et al. Clinical Gastroenterology and Hepatology
- From NASH to HCC: current concepts and future challenges
- (2019) Quentin M. Anstee et al. Nature Reviews Gastroenterology & Hepatology
- United States Valuation of EQ-5D-5L Health States Using an International Protocol
- (2019) A. Simon Pickard et al. VALUE IN HEALTH
- Review and critical appraisal of studies mapping from quality of life or clinical measures to EQ-5D: an online database and application of the MAPS statement
- (2018) Helen Dakin et al. Health and Quality of Life Outcomes
- Minimally Important Difference of the EQ-5D-5L Index Score in Adults with Type 2 Diabetes
- (2018) Nathan S. McClure et al. VALUE IN HEALTH
- Health-related Quality of Life in Non-alcoholic Fatty Liver Disease Associates With Hepatic Inflammation
- (2018) Yvonne Huber et al. Clinical Gastroenterology and Hepatology
- Mapping to Estimate Health-State Utility from Non–Preference-Based Outcome Measures: An ISPOR Good Practices for Outcomes Research Task Force Report
- (2017) Allan J. Wailoo et al. VALUE IN HEALTH
- Prevalence and recognition of obesity and its associated comorbidities: cross-sectional analysis of electronic health record data from a large US integrated health system
- (2017) Kevin M Pantalone et al. BMJ Open
- Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus
- (2016) Kristy Iglay et al. CURRENT MEDICAL RESEARCH AND OPINION
- Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme
- (2016) S M Babineaux et al. BMJ Open
- Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015
- (2016) Victoria Higgins et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- The MAPS Reporting Statement for Studies Mapping onto Generic Preference-Based Outcome Measures: Explanation and Elaboration
- (2015) Stavros Petrou et al. PHARMACOECONOMICS
- Comparing the EQ-5D 3L and 5L: measurement properties and association with chronic conditions and multimorbidity in the general population
- (2014) Calypse B Agborsangaya et al. Health and Quality of Life Outcomes
- Use of generic and condition-specific measures of health-related quality of life in NICE decision-making: a systematic review, statistical modelling and survey
- (2014) Louise Longworth et al. HEALTH TECHNOLOGY ASSESSMENT
- Mapping EQ-5D Utility Scores from the Incontinence Quality of Life Questionnaire among Patients with Neurogenic and Idiopathic Overactive Bladder
- (2013) Stephen Kay et al. VALUE IN HEALTH
- Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
- (2011) G. Vernon et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Relationship Between Obesity and Diabetes in a US Adult Population: Findings from the National Health and Nutrition Examination Survey, 1999–2006
- (2010) Ninh T. Nguyen et al. OBESITY SURGERY
- Quality of life in adults with nonalcoholic fatty liver disease: Baseline data from the nonalcoholic steatohepatitis clinical research network
- (2009) Kristin David et al. HEPATOLOGY
- Real-world physician and patient behaviour across countries: Disease-Specific Programmes – a means to understand
- (2008) P. Anderson et al. CURRENT MEDICAL RESEARCH AND OPINION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started